BELIEVE: Phase III Study of Luspatercept vs Placebo in Beta-Thalassemia

Final OS data for PAOLA-1 phase III trial of maintenance olaparib plus bevacizumab vs placebo plus bevacizumab in newly diagnosed ovarian cancer, presented at ESMO 2022 and reported by Clinical Care Options (CCO)

Downloadable slideset from Antonio Urbina, MD, on HIV infection in the transgender population, including strategies for improving patient care and PrEP uptake, from Clinical Care Options (CCO)

Antonio E. Urbina, MD Released: September 27, 2022

Antonio Urbina, MD, discusses HIV infection in the transgender population, including strategies for improving patient care and PrEP uptake, from Clinical Care Options (CCO)

Antonio E. Urbina, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: September 27, 2022 Expired: September 26, 2023

Downloadable slideset updated with highlights of key gynecologic oncology studies presented at conferences throughout 2022, from Clinical Care Options (CCO)

Jubilee Brown, MD Elisabeth Diver, MD Alexandra Leary, MD, PhD Domenica Lorusso, MD, PhD David Scott Miller, MD, FACOG, FACS Angeles Alvarez Secord, MD, MHSc Released: September 26, 2022